Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase

Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2019

Region

Worldwide

Survey time period

February 28, 2019

Supplementary notes

* Twelve programs listed as “Ex-US” in the Biomedtracker database are included here by phase based on independent research of company websites. This “Ex-US” listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer’s Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer’s disease are shown.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Dementia and Alzheimer's disease in Europe "

Other statistics that may interest you Dementia and Alzheimer's disease in Europe

World overview

6

European focus

5

Mortality and morbidity

8

Situation in specific countries

8

Policies directed towards dementia

8

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.